Peripheral SNCA+ cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer
{{output}}
Background: We previously demonstrated that immune cells expressing α-synuclein (SNCA) are dramatically increased in peripheral blood of patients with gastric cancer (GC), but rarely in healthy donors, and that blocking SNCA is ... ...
